Gabriela Antelo

ORCID: 0000-0001-6394-7750
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Advanced Radiotherapy Techniques
  • Radiomics and Machine Learning in Medical Imaging
  • Brain Metastases and Treatment
  • Endometrial and Cervical Cancer Treatments
  • Lung Cancer Research Studies
  • Glioma Diagnosis and Treatment
  • Advances in Oncology and Radiotherapy
  • Radiation Dose and Imaging
  • Childhood Cancer Survivors' Quality of Life
  • Cardiac Imaging and Diagnostics
  • Colorectal Cancer Surgical Treatments
  • Hematopoietic Stem Cell Transplantation
  • Colorectal and Anal Carcinomas
  • Radiation Therapy and Dosimetry
  • Lymphoma Diagnosis and Treatment
  • Economic and Financial Impacts of Cancer
  • Angiogenesis and VEGF in Cancer
  • Esophageal Cancer Research and Treatment
  • Acute Lymphoblastic Leukemia research
  • Lymphatic System and Diseases
  • Prostate Cancer Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Neuroblastoma Research and Treatments
  • Medical Imaging Techniques and Applications

Hospital Clínic de Barcelona
2022-2024

Universitat de Barcelona
2022-2023

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer
2022

Institut Català d'Oncologia
2018-2020

Hospital Universitari Germans Trias i Pujol
2018-2019

Agostino Gemelli University Polyclinic
2019

Istituti di Ricovero e Cura a Carattere Scientifico
2019

This study investigates early cardiac events (ECEs) occurring during the first 180 days after allogeneic hematopoietic cell transplant (allo-HCT) in 416 adults receiving posttransplant cyclophosphamide (PTCY) (n = 258) or not PTCY 158). Total body irradiation (TBI) was given to 133 (31.9%) patients, of whom 111 (83.4%) received TBI combined with PTCY. The day +180 cumulative incidence function (CIF) ECEs 8.4%, heart failure 13) and pericardial complications 11) being most prevalent...

10.1182/bloodadvances.2022008792 article EN cc-by-nc-nd Blood Advances 2022-12-01

Patients with advanced-stage Hodgkin lymphoma treated ABVD who have a positive interim FDG-PET (iPET) poor prognosis. Escalation to BEACOPP has been shown improve progression-free survival (PFS). However, randomized trials are lacking determine the best strategy for intensification. We report on A-AVD escalation treatment outcomes 15 iPET-positive patients post-ABVD. Overall response and complete rates were 80% 60%, respectively. Four underwent salvage therapy followed by autologous stem...

10.1002/hon.3299 article EN Hematological Oncology 2024-08-12

Analyse the impact of different prognostic factors on G2-late vaginal complications after brachytherapy (VBT) ± external beam radiotherapy (EBRT) in postoperative endometrial cancer (PEC).One hundred and twenty-six PEC patients treated with VBT EBRT were retrospectively analysed considering age, body mass index, applicator diameter, clinical target volume (CTV), use dilators, chemotherapy EQD2(α/β=3) at most exposed 2 cm3 CTV as for complications. Late evaluated using objective LENT-SOMA...

10.1007/s12094-023-03099-4 article EN cc-by Clinical & Translational Oncology 2023-02-08

Endoesophageal brachytherapy (EBT) or endoesofageal interventional radiotherapy (EIRT) is an effective technique that has been used with varying frequency for many years. It a very good in T1-T2 inoperable esophageal cancer and the palliation of dysphagia. However, only some centers have access to this technique, consequently, it underused. Here, we discussed indications several technical aspects as well literature available. Also, why underused how can be overcome. We consider EBT should...

10.5114/jcb.2022.117726 article EN cc-by-nc-sa Journal of Contemporary Brachytherapy 2022-01-01

Abstract BACKGROUND Glioblastoma (GB) has a poor prognosis with median overall survival of 12-14 months. According to literature, patients surviving more than two years progressively increased since 2005 and represent approximately 18% this population, being considered long-term survivors (LTS). The aim study is retrospectively analyze GB LTS treated in our Neurooncology Unit. MATERIAL AND METHODS From December 2009 March 2021, 49 were identified oncology data base, representing 21,7%...

10.1093/neuonc/noad137.264 article EN Neuro-Oncology 2023-09-01
Coming Soon ...